AdaptHealth (NASDAQ: AHCO) furnishes Q3 2025 earnings press release in 8-K

Rhea-AI Filing Summary

AdaptHealth Corp. furnished an update on its recent performance by issuing a press release with financial results for the quarter ended September 30, 2025. The company released these results on November 4, 2025 and attached the full press release as an exhibit to this report.

The disclosure is provided under the results of operations and financial condition section and is treated as “furnished” rather than “filed,” which limits certain legal liabilities. The press release is identified as Exhibit 99.1, with an additional exhibit covering the interactive data for the cover page.

FALSE000172525500017252552025-11-042025-11-04

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

___________________________________

FORM 8-K

___________________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

November 4, 2025

Date of Report (date of earliest event reported)

AdaptHealth Corp.

(Exact name of registrant as specified in its charter)

Delaware

001-38399

82-3677704

(State or other jurisdiction of incorporation or organization)

(Commission File Number)

(I.R.S. Employer Identification Number)

555 East North Lane, Suite 5075, Conshohocken, PA 19428

(Address of principal executive offices and zip code)

(610) 424-4515

(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of each exchange on which registered

Common Stock, par value $0.0001 per share

AHCO

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company    ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 - Results of Operations and Financial Condition.

The following information is furnished pursuant to Regulation FD.

On November 4, 2025, AdaptHealth Corp. (the "Company") issued a press release (the “Press Release”) announcing financial results for the quarter ended September 30, 2025. A copy of the Press Release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information in this Item 2.02 (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, regardless of any general incorporation language in such filing, unless expressly incorporated by reference in such filing.

Item 9.01 - Financial Statements and Exhibits

(d)    Exhibits

Exhibit No.						Description
99.1						Press Release dated November 4, 2025 announcing the earnings results for the quarter ended September 30, 2025.
104						Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

Dated: November 4, 2025

AdaptHealth Corp.
By:			/s/ Jason Clemens
Name:			Jason Clemens
Title:			Chief Financial Officer

FAQ

What did AdaptHealth Corp. (AHCO) report in this 8-K filing?

AdaptHealth Corp. reported that it issued a press release announcing financial results for the quarter ended September 30, 2025. The press release is attached as Exhibit 99.1 and contains the detailed earnings information.

When did AdaptHealth Corp. (AHCO) release its quarterly financial results?

AdaptHealth Corp. released its quarterly financial results on November 4, 2025. On that date, it issued a press release covering results for the quarter ended September 30, 2025 and furnished it as an exhibit to this report.

Which quarter’s results are covered by AdaptHealth Corp.’s (AHCO) press release?

The press release covers AdaptHealth Corp.’s financial results for the quarter ended September 30, 2025. This period’s performance details are included in Exhibit 99.1, which is furnished alongside the current report.

How are the AdaptHealth Corp. (AHCO) earnings results treated under securities laws?

The earnings results are treated as information that is “furnished” rather than “filed” under the Exchange Act. This treatment limits certain liabilities and means the press release is not automatically incorporated into other securities filings.

What exhibits are included with this AdaptHealth Corp. (AHCO) 8-K?

The 8-K includes Exhibit 99.1, a press release dated November 4, 2025 announcing earnings results for the quarter ended September 30, 2025, and Exhibit 104, the cover page interactive data file embedded in the Inline XBRL document.

Under which item did AdaptHealth Corp. (AHCO) furnish its earnings press release?

AdaptHealth Corp. furnished its earnings press release under Item 2.02, Results of Operations and Financial Condition. The information is also provided pursuant to Regulation FD and is incorporated by reference only if expressly stated elsewhere.